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ABSTRACT 26 
Objectives: The objectives of this work were to enumerate and characterize the 27 
pathogenic potential of the Bacillus population that may survive Holder pasteurization 28 
of human milk and to evaluate the nutritional damage of this treatment using the 29 
furosine and lactulose indexes.  30 
Materials and Methods: Milk samples from 21 donors were heated at 62.5C for 30 31 
minutes. Bacterial counts, lactose, glucose, myo-inositol, lactulose and furosine were 32 
determined before and after the heat treatment. Some Bacillus cereus isolates that 33 
survived after pasteurization were evaluated for toxigenic potential. 34 
Results: Non-pasteurized milk samples showed bacterial growth in most of the agar 35 
media tested. Bacterial survival after pasteurization was only observed in three samples 36 
and, in these cases, the microorganisms isolated belonged to the species B. cereus. 37 
Furosine could not be detected in any of the samples while changes in lactose, glucose, 38 
and myo-inositol concentrations after Holder pasteurization were not relevant. Lactulose 39 
was below the detection limit of the analytical method in non pasteurized samples while 40 
it was found at low levels in 62% of the samples after Holder pasteurization. The 41 
lactation period influenced myo-inositol content since its concentration in transition 42 
milk was significantly higher than in mature or late lactation milk samples.  43 
Conclusions: Holder pasteurization led to the destruction of bacteria present initially in 44 
donor milk samples, except some B. cereus that did not display a high virulence 45 
potential, and did not modify significantly the concentration of the compounds analyzed 46 
in this work. 47 
 48 
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INTRODUCTION 51 
Human milk is widely recognized as the optimal feeding option for human term 52 
and preterm infants because of the wide spectrum of short-, medium- and long-term 53 
potential benefits that it provides (1). Unfortunately, there are cases where mother's own 54 
milk is not available or enough to cover the requirements of the newborn. Therefore, 55 
there is a worldwide increasing demand for donor breast milk, particularly for preterm 56 
infants and older infants suffering from diverse medical problems (2). In such 57 
situations, clinicians value the importance of banked human milk, not only as a 58 
nutritional option, but also as a potentially life-saving therapy. 59 
Up to date, there are not worldwide uniform guidelines for the screening, 60 
processing, storage and handling of donor milk among Milk Banks and, in fact, 61 
protocols may vary even in banks operating in the same country. However, the potential 62 
mother-to-child transmission of certain viruses, such as human immunodeficiency virus 63 
(HIV), human T-lymphoma virus (HTLV) or cytomegalovirus, through breastfeeding, 64 
together with the difficulties in an exhaustive surveillance of donors’ health (including 65 
repetitive serum screening), has led to the systematic pasteurization of donor milk in the 66 
vastly majority of Human Milk Banks. Human pasteurized milk is considered as the 67 
best alternative to non-heated frozen or fresh milk, and has been shown to reduce the 68 
incidence of necrotizing enterocolitis, sepsis, and other infections in premature and high 69 
risk infants, resulting in shorter hospital stays (3,4,5). 70 
Although some nutrients and bioactive compounds present in fresh human milk 71 
remain active after such heat treatment, the biological activity of others compounds is 72 
affected at a variable degree (6,7,8,9,10). As a consequence, questions arise concerning 73 
the effects of heat processing on some of the unique components of human milk.  74 
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Because of its content in lactose and proteins, heating of human milk can induce 75 
chemical changes of important nutrients, leading to adverse nutritional effects (11). The 76 
damage extent produced by heating can be measured through the use of chemical 77 
indexes, such as the furosine (2-furoylmethyl-lysine) and lactulose (4-O-β-D-78 
galactopyranosyl-D-fructofuranose) levels. Furosine is used as an indirect measurement 79 
of Amadori compounds formed in the early stages of Maillard reaction between proteins 80 
(-amino group of protein-bound lysine) and sugar components (carbonyl group of 81 
reducing sugar as lactose) during processing (12). Lactulose is a synthetic sugar, which 82 
does not occur naturally and it is produced from lactose by isomerization in basic 83 
media. This disaccharide is absent in raw milk but the dissolved salt system of milk is a 84 
buffered solvent favourable to the formation of lactulose from lactose during heat 85 
treatment of milk (13). Both, furosine and lactulose are useful markers for evaluating 86 
the extent of heat damage in milk and infant formulas (14,15).  87 
In addition, breast milk is a source of commensal and potentially probiotic 88 
bacteria (16,17), which seems to play an important role in gut colonization of the 89 
healthy infant (17,18). Such bacteria are killed by the pasteurization process. It is 90 
important to note that spore-forming bacteria that may survive the heating process, such 91 
as Bacillus cereus, or microorganisms that could contaminate milk after pasteurization 92 
can grow faster than in raw milk because of the heat damage to the milk bacteriostatic 93 
systems, including the absence of natural competitors (6). 94 
In this context, the objectives of this work were, on one hand, to enumerate and 95 
characterize the pathogenic potential of the Bacillus population that may survive Holder 96 
pasteurization and, on the other hand, to evaluate the potential nutritional damage of this 97 
thermal treatment using the furosine and lactulose indexes. 98 
 99 
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MATERIAL AND METHODS 100 
 101 
Breast milk samples 102 
Breast milk samples (8 mL) were obtained from the Human Milk Bank located 103 
at the Hospital Universitario 12 de Octubre (Madrid, Spain). Milk collection was 104 
performed following a specific protocol for donor mothers approved by the local ethical 105 
committee. The samples were obtained from 21 donors that fulfilled the requirements of 106 
the Bank and informed consent was obtained from each donor. Milk was collected at 107 
home using electric (Lactaline; Ameda, Lincolnshire, USA) or manual (Harmony or 108 
Lactaset models; Medela, Baar, Switzerland) pumps. An aliquot from each milk sample 109 
was separated before pasteurization while the rest of the sample was pasteurized by 110 
heating it at 62.5C for 30 minutes; then, it was cooled in a shaking water bath (Lab 111 
Companion, Seoul, Korea) filled with ice-cold water and provided of temperature 112 
control. Once the temperature reached 4ºC (always within the first 15 minutes of 113 
cooling), it was stored at -20ºC until its analysis. A thermometer, coupled to an external 114 
sensor of temperature (DT 132, Fourier, Fairfield, USA), was introduced in a control 115 
bottle (cow’s milk), and used as a probe to monitor the temperature of the milk batch 116 
during the whole heating/cooling process. 117 
 118 
Bacterial cultures and identification of isolates 119 
Proper peptone water dilutions of 21 pairs of milk samples (21 before and 21 120 
after pasteurization) were plated onto Brain Heart Infusion (BHI, Oxoid, Basingstoke, 121 
UK; a general-purpose medium suitable for the cultivation of non-fastidious bacteria, 122 
yeasts and moulds), Columbia Nadilixic Acid Agar (CNA, BioMerieux; a highly 123 
nutritious, general-purpose medium for the isolation and cultivation of fastidious 124 
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microorganisms), Baird Parker (BP, BioMerieux; a selective medium for the isolation of 125 
staphylococci), MacConkey (MCK, BioMerieux; a selective medium for the isolation of 126 
enterobacteria), Polymyxin-Pyruvate-Egg Yolk-Mannitol with Bromothymol Blue 127 
(PEMBA, Oxoid; a selective medium for the isolation of Bacillus), and de Man, 128 
Rogosa, and Sharpe (MRS, Oxoid; a medium for the isolation of lactic acid bacteria) 129 
agar plates, which were aerobically incubated at 37C for 24-48 hours. Parallel, the 130 
samples were also cultured on Wilkins Chalgren (WCh, Oxoid; a general medium for 131 
isolating anaerobic bacteria), which were incubated anaerobically (85% nitrogen, 10% 132 
hydrogen, 5% carbon dioxide) in an anaerobic workstation (MINI-MACS, DW 133 
Scientific, Shipley, UK) at 37ºC for 48 hours. Colonies, from the plates where bacterial 134 
growth was detected, were isolated and stored at -20C in the presence of glycerol 135 
(20%, v/v). 136 
Identification of the isolates was performed by PCR sequencing of a 470 pb 137 
fragment of the 16S rRNA gene as described previously (19). The amplicons were 138 
purified using the Nucleospin Extract II kit (Macherey-Nagel, Düren, Germany) and 139 
sequenced at the Genomics Unit of the Complutense University of Madrid, Spain. The 140 
resulting sequences were used to search sequences deposited in the EMBL database 141 
using BLAST algorithm and the identity of the isolates was determined on the basis of 142 
the highest scores (>98%). 143 
Since the genomes of the B. cereus group of species, including B. cereus and B. 144 
anthracis, are closely related both in gene content and synteny (20) and their 16S rRNA 145 
gene sequences share greater than 99% similarity (21), those isolates identified as B. 146 
cereus were submitted to a repetitive element polymorphism PCR (rep-PCR) assay to 147 
assure that they did not belong to the B. anthracis species. For this purpose, the BOX-148 
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A1R primer, which originates a 390 bp fragment if B. anthracis DNA is present in the 149 
sample, was used as described previously (22). 150 
 151 
Genetic profiling of the B. cereus isolates and evaluation of their toxigenic potential 152 
A collection of 49 B. cereus isolates, including those obtained in this work and 153 
those obtained from other samples of pasteurized donor milk that were previously 154 
rejected by the same Milk Bank because of the presence of this bacterial species, were 155 
typed by random amplification polymorphic DNA (RAPD), using primer OPL5 (5’-156 
ACG CAG GCA C-3’) as described previously (23).  157 
Then, presence of genes involved in the biosynthesis of the main B. cereus 158 
toxins was evaluated. In relation to the toxins responsible for food poisoning by B. 159 
cereus, cereulide is associated to the emetic symptoms and is encoded by cereulide 160 
synthetase (ces) gene cluster while three pore-forming toxins appear to be responsible 161 
for the diarrhoeal symptoms: hemolysin BL (Hbl), non-haemolytic enterotoxin (Nhe), 162 
and cytotoxin K (CytK-1 or CytK-2) (24). Hbl consists of the three proteins L2, L1 and 163 
B, encoded by the genes hblC, hblD and hblA, respectively; Nhe is composed of the 164 
proteins NheA, NET and NheC, encoded by the nheABC operon; finally, CytK-1 or -2 165 
are single-component toxins. In order to detect the presence of toxin gene determinants, 166 
total genomic DNA from each B. cereus strain was extracted by disrupting colonies in 167 
deionized water and in a (chloroform:isoamylic alcohol):water (1:1, v:v) solution. Then, 168 
three multiplex PCR assays were used for the detection of the hblCDA and nheABC 169 
operons and the ces gene cluster using primer sets and PCR conditions previously 170 
described (25). Parallel, a duplex PCR assay was performed to detect genes encoding 171 
CytK-1 and CytK-2 (26). Presence of toxins Hbl and Nhe in culture supernatants of 172 
same B. cereus isolates was also analyzed with the Gold Labelled ImmunoSorbent 173 
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Assay (GLISA)-Rapid Test for the qualitative detection of B. cereus enterotoxins 174 
(Merck, Darmstadt, Germany) following the instructions of the manufacturer.  175 
 176 
Determination of furosine  177 
Determination of furosine in the 21 pairs of milks samples was performed by 178 
ion-pair RP-HPLC following the method of Resmini et al. (27). Before analysis, milk 179 
samples (2 mL) were hydrolyzed with 6 mL of 10.6 N HCl under inert conditions at 180 
110ºC for 24 h in a Pyrex screw-cap vial with PTFE-faced septa. The hydrolysate was 181 
filtered through Whatman Nº 40 filter paper, and, 0.5 mL of filtrate were applied to a 182 
previously activated Sep-Pak C18 cartridge (Millipore). Furosine was eluted with 3 mL 183 
of 3N HCl and 20 L was injected into the chromatograph.  184 
RP-HPLC analysis of furosine was carried out in a C8 column (250 mm  4.6 185 
mm, 5 m) (Alltech furosine-dedicated) maintained at 35C using a linear binary 186 
gradient at a flow rate of 1.2 mL/min. Mobile phase was constituted by solvent A, 0.4% 187 
acetic acid, and solvent B, 0.3% KCl in phase A. Detection was performed using a 188 
variable wavelength UV detector at 280 nm (LDC Analytical, SM 4000). Acquisition 189 
and processing of data were achieved with a HPChem Station (Hewlett-Packard). 190 
Calibration was performed by external standard method using commercial standard of 191 
pure furosine (Neosystem Laboratories, Strasbourg, France). The detection limit (LOD) 192 
of RP-HPLC method was 1.16 mg/100 mg of protein. 193 
The determination of protein concentration was done following the Bradford 194 
procedure (BioRad) using albumin as external standard. 195 
 196 
GC Analysis of Carbohydrates  197 
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Lactose, glucose, lactulose and myo-inositol were also determined, by GC, in the 198 
21 pairs of milk samples, following the method of Montilla et al. (28). For this purpose, 199 
0.2 mL of sample was made up to 2 mL with methanol in a volumetric flask to remove 200 
proteins and fat. Mixtures were vigorously stirred, followed by standing for at least 1 h. 201 
The supernatant was used for carbohydrate analysis and a solution of 0.1% (w:v) 202 
phenyl-β-D-glucoside in methanol/water (70:30, v/v) was added as internal standard. 203 
Before derivatization, equal volumes (0.5 mL) of supernatant and internal 204 
standard solution were mixed and dried at 38–40ºC in a rotary evaporator. The dried 205 
mixtures were treated with 100 µL N,N-dimethylformamide and held at 70ºC for 1 h to 206 
obtain a constant anomeric composition. Then, 100 µL of N-trimethylsilylimidazole 207 
were added to silylate the carbohydrates and the reaction was completed in 30 min at 208 
70ºC. Silylated carbohydrates were extracted with 0.1 mL of hexane and 0.2 mL of 209 
water. Volumes in the range of 0.2–1 µl of the organic phase containing silyl-210 
derivatives were injected into the column.  211 
The trimethylsilyl ethers of carbohydrates were analyzed in an Agilent 212 
Technologies 7890A gas chromatograph equipped with a commercial 30 m  0.32 mm 213 
inside diameter, 0.5 µm film fused silica capillary column SPBTM–17, bonded, 214 
crosslinked phase (50% diphenyl/50% dimethylsiloxane) (Supelco, 595 North Harrison 215 
Road, Bellefonte, PA, USA). Separation was performed at 235ºC for 9 min, followed by 216 
an increase up to 270ºC at rate of 15ºC/min and keeping this temperature for 15 min. 217 
Temperatures of injector and flame ionisation detector were 300ºC during the analysis. 218 
Injections were carried out in split mode 1:30, using 1 mL/min of nitrogen as carrier 219 
gas. Data acquisition and integration were performed using Agilent Chem-Station Rev. 220 
B.03.01 software (Wilmington, DE). To study the response factor relative to the internal 221 
standard, solutions containing lactose, lactulose, glucose and myo-inositol were 222 
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prepared over the expected concentration range in milk samples. The identity of 223 
carbohydrates present in milk samples were confirmed by comparison with relative 224 
retention times of standard samples. 225 
 226 
Statistical Analysis 227 
Microbiological data, recorded as colony forming units (CFU) per mL of milk, 228 
were transformed to logarithmic values before statistical analysis. Quantitative 229 
biochemical data were expressed as mean  standard deviation (SD) and 95% 230 
confidence interval (CI) of the mean. Values were tested for normality of distribution. 231 
Correlations between lactose, glucose, and myo-inositol concentration and lactation time 232 
were determined by the Spearman method. The effect of Holder pasteurization on sugar 233 
concentrations was evaluated with paired Student’s t-tests. The influence of the lactation 234 
period (transition milk, mature milk, and late lactation milk) in lactose, glucose, and 235 
myo-inositol concentration was analyzed by one-way ANOVA followed by 236 
Bonferroni’s multiple comparison tests. Statistical tests were considered significant at P 237 
< 0.05. The SAS system (Statistical Analysis Systems Institute Inc., Cary, NC, USA) 238 
was used to perform these analyses. 239 
 240 
 241 
RESULTS 242 
 243 
Bacterial counts in the milk samples and identification of the isolates 244 
To evaluate the effect of Holder pasteurization on the viability of the milk 245 
bacteria, 21 samples of donor milk were cultured before and after heating at 62.5C for 246 
30 minutes. In all cases, inoculation of non-pasteurized milk samples in BHI, CNA, BP, 247 
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MRS, WCh and PEMBA agar plates led to bacterial growth (Table 1). In contrast, 248 
bacteria only could be isolated from 13 (62%) of the same samples when inoculated on 249 
MCK plates (Table 1). Globally, the bacterial counts in non-pasteurized samples 250 
oscillated between 2.60 and 5.22 log10 CFU/mL in BHI medium, with a mean (SD; 95% 251 
CI) value of 3.93 (0.85, 3.54 – 4.31) log10 CFU/mL. The lowest mean bacterial counts 252 
of donor milk samples were found in MRS medium, and were 0.88 log10 CFU/mL lower 253 
than in BHI agar plates (Table 1). In the samples in which growth was observed on 254 
MCK agar plates (n=13), the counts oscillated between 1.70 and 4.92 log10 CFU/mL.  255 
Most of the bacteria isolated from the raw milk samples, both qualitatively and 256 
quantitatively, belonged to the genera Staphylococcus (BHI, CNA, MRS, WCh agar 257 
plates), Streptococcus (CNA, MRS, WCh agar plates), and Bacillus (PEMBA), or to the 258 
Lactobacillus group (MRS). When growth was observed on MCK plates, all the isolates 259 
belonged to the coliform group and, most of them, to the species Escherichia coli or to 260 
the genus Enterobacter. 261 
Pasteurization had a radical effect on the bacterial population of the samples 262 
(Table 1); in fact, bacterial growth could not be detected from most pasteurized samples 263 
after culturing onto BHI, MCK, CNA, BP, MRS or WCh agar plates. Bacterial survival 264 
after pasteurization was observed in one sample when cultured on BHI (1.7 log10 265 
CFU/mL) and PEMBA (3.44 log10 CFU/mL) agar plates, and in two additional samples 266 
when cultured on PEMBA agar plates (both at a concentration of ~2.0 log10 CFU/mL) 267 
(Table 1). In all these cases, the microorganisms isolated belonged to the species B. 268 
cereus. A very low number of colonies (n=1–3; dilution 0) of staphylococci or 269 
propionibacteria were observed in two samples but their presence seemed to be due to 270 
post-processing contamination since these isolates did not survive Holder pasteurization 271 
 12 
when they were inoculated in sterile milk at an initial concentration of ~4.0 log10 272 
CFU/mL (results not shown). 273 
 274 
Genetic profiling of the B. cereus isolates and evaluation of their toxigenic potential 275 
RAPD profiling of the B. cereus isolates showed the presence of six different 276 
band patterns. Interestingly, each RAPD profile was coincident with one of the six toxin 277 
gene profiles observed among the 49 isolates (Table 2). 278 
None of the isolates harboured neither the ces gene, associated to the 279 
biosynthesis of the emetic toxin, nor cytK1 while all carried those required for Nhe 280 
production. The cytK2 gene was present in approximately 50% of the isolates. Finally, 281 
only one strain (~2%) harboured the complete hblCDA operon. The results obtained 282 
with the GLISA immunoassays (detection of toxins in culture) were in agreement with 283 
the presence of the genes as determined by multiplex PCR. Nhe toxin could be detected 284 
in cultures of the nheABC-positive strains while Hbl toxin could only be detected in the 285 
strain that harboured the complete hblCDA operon (Table 2).  286 
 287 
Effect of pasteurization and lactation period on the concentrations of furosine and 288 
carbohydrates 289 
In this study, no peak of furosine was detected in any of the samples, neither 290 
before nor after the pasteurization process; therefore, holder pasteurization did not 291 
favour Maillard reaction.  292 
Lactose, glucose, myo-inositol, and lactulose concentrations in donor milk 293 
samples are presented in Table 3. Mean (SD; 95% CI) concentration of lactose in non-294 
pasteurized milk samples was 64.08 (6.14; 61.28 – 66.88) g/L. Glucose and myo-295 
inositol were found in all samples at approximately three orders of magnitude lower 296 
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concentration than lactose and showed considerable sample-to-sample variation, i.e. 297 
206.45 (78.79; 170.59 – 242.32) mg/L for glucose and 196.45 (104.40; 148.93 – 298 
243.97) mg/L for myo-inositol. However, glucose and myo-inositol concentrations were 299 
not related in each individual milk sample; in fact the ratio [glucose]/[myo-inositol] 300 
varied from 0.33 to 3.05, and only 5 samples showed similar amounts of both 301 
compounds (glucose/myo-inositol = 0.91 – 1.17). There was no correlation between 302 
lactose, glucose, and myo-inositol concentrations in milk samples (data not shown).  303 
Changes in lactose, glucose, and myo-inositol concentrations in milk samples 304 
after Holder pasteurization were not relevant, although mean lactose concentration 305 
(expressed as mean  SD) increased by 1.42  2.89 g/L (paired Student’s t-test, P = 306 
0.036) and mean glucose and myo-inositol concentrations decreased by 6.82  14.75 307 
mg/L and 1.61  19.95 mg/L, respectively (paired Student’s t-test, P = 0.047 and P = 308 
0.716, respectively). Lactulose was below the detection limit of the analytical method 309 
(10 mg/L) in non pasteurized milk samples, and it was found in 62% of the samples 310 
after Holder pasteurization with a mean concentration of 18.96  6.14 mg/L (Table 3).  311 
Since milk samples were donated by women at different lactation periods, 312 
between 6 days and 1.9 years, Spearman’s correlation coefficients were calculated in 313 
order to compare the relationship between the concentration of lactose, glucose and 314 
myo-inositol in human milk samples and the lactation time (in days). Lactose and 315 
glucose concentration had poor correlation with the length of lactation (Spearman r = -316 
0.302, P = 0.1836 for lactose and r = 0.155, P = 0.503 for glucose) but there was a 317 
strong negative and significant correlation between myo-inositol concentration and the 318 
lactation time (Spearman r = -0.752, P = <0.0001).  319 
Lactose, glucose and myo-inositol concentration in human milk samples as a 320 
function of three different lactation periods is shown in Figure 1. Lactose and glucose 321 
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concentrations were slightly higher in mature milk (15-180 days) samples than in 322 
transition milk (< 15 days) and in late lactation milk (180-250 days of lactation), but 323 
these differences were not statistically significant. In contrast, the lactation period had a 324 
significant effect on myo-inositol concentration (one-way ANOVA, F-value = 11.65, P-325 
value = 0.0006). The concentration of myo-inositol in transition milk (341.35  95.22 326 
mg/L, n = 4) was significantly higher than in mature (198.04  80.14 mg/L, n = 8, P < 327 
0.05) and late lactation (130.64  53.44 mg/L, n = 9, P < 0.001) milk samples (Figure 328 
1).  329 
 330 
DISCUSSION 331 
In this study, bacteria could be isolated from non-pasteurized human milk in 332 
different culture media. This finding is not strange since fresh human milk contains a 333 
number (<3 log10 CFU/mL) of viable bacteria and a wide range of free bacterial DNA 334 
signatures which may program the neonatal immune system (29). In fact, breast milk 335 
has been shown to be a continuous source of commensal and potentially probiotic 336 
bacteria to the infant gut, including staphylococci, streptococci, bifidobacteria and lactic 337 
acid bacteria (16,17,30).  338 
The fact that, in this study, donors extracted the milk using pumps may explain 339 
why many samples had counts higher than 3 log10 CFU/mL and why growth was 340 
observed in 62% of samples when cultured on MCK agar plates. It has been shown that 341 
the use of milk pumps to collect the samples is associated to a higher level of bacteria, 342 
and particularly enterobacteria, which are not related to the usual breast milk microbiota 343 
(31). Contamination of milk during pumping has been reported previously and seems to 344 
be of particular concern for premature infants or ill infants in neonatal intensive care 345 
units (32,33). Many milk pumps and/or their accessories can not be properly sanitized 346 
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and/or sterilized and bacteria usually persist after application of current cleaning 347 
protocols. Therefore, the design of new pumping devices that can be sterilized and 348 
subjected to more efficient cleaning and disinfection procedures is highly desirable. 349 
Holder pasteurization of the milk samples led to the destruction of the bacteria 350 
present in the initial fresh samples with the exception of three samples in which B. 351 
cereus could be isolated. Similarly, a recent study revealed that 93% of milk samples 352 
submitted to Holder pasteurization showed no bacterial growth on cultures and that 353 
Bacillus sp. was the predominant contaminant in those that were positive after 354 
pasteurization (34). B. cereus is described as being of ubiquitous presence in nature; in 355 
addition to a full life cycle in soil, where it is richly present, it is also adapted to human 356 
hosts, either as a pathogen or, more frequently, as a part of the intestinal microbiota of a 357 
healthy host (24). Additionally, it has been found in breast milk of healthy rhesus 358 
monkeys (35) and in the udder of cows (36). The possible adaptation of B. cereus to the 359 
environment of the animal gut could be the basis of their proposed probiotic effect. In 360 
fact, certain strains producing negligible amounts of toxin at 37ºC have been approved 361 
for probiotic use by the European Food Safety Authority (EFSA) (24). However, as the 362 
level of virulence is highly variable among different strains, caution is strongly required 363 
when dealing with this species. 364 
In contrast to vegetative cells, spores of B. cereus can survive different heat 365 
treatments, including Holder pasteurization. As a consequence, this species is a 366 
common inhabitant of milk (36,37), and it can cause a defect known as sweet curdling 367 
in dairy products. Considering the non fastidious nature of this microorganism, no type 368 
of food with pH < 4.8 can be excluded as a risk of food spoilage or foodborne disease 369 
(38). Failure to follow basic food preparation rules, such as slow or inadequate cooling, 370 
storage at ambient temperature or prolonged heat-keeping at approximately 60ºC, may 371 
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allow growth of B. cereus. Therefore, these hygienic rules are critical in a Milk Bank 372 
providing milk to preterm neonates. It should be had in account that a negative result for 373 
Bacillus in a post-pasteurization culture does not mean that this microorganism is 374 
absent; it only means that this species is under the detection limit of the technique (for 375 
example, 100 CFU/mL if 10 l of milk were cultured). 376 
Two distinct foodborne disease types, emetic and diarrhoeal, are associated with 377 
B. cereus. For the both types, 3-8 log10 CFU cells or spores have been indicated as the 378 
infective dose (24,38). The count of B. cereus in a confirmed foodborne outbreak in 379 
Norway was as low as 2 log10 CFU/g of food (39) although further research showed that 380 
the actual number was closer to 4 log10 CFU/g, and that the underestimation was due 381 
because the bacilli were being present as aggregated spores (24). While the role of 382 
cereulide in causing the emetic syndrome of B. cereus is well established, that of the 383 
cytotoxins as etiological agents of diarrhoeal disease is not so clear. Strong evidences 384 
indicate that Hbl, Nhe and CytK cytotoxins are virulence factors usually involved in B. 385 
cereus foodborne diarrhoeal disease but there are difficulties in establishing a single 386 
factor as the etiological agent of gastroenteritis due to this species; this fact reflects that, 387 
most probable, the disease is multifactorial and that a number of additional virulence 388 
factors may contribute to the overall cellular damage, possibly in a strain-dependent 389 
manner. In this study, no strain harboured genes responsible for the biosynthesis of the 390 
emetic toxin while all carried those required for Nhe production. However, genes 391 
encoding Nhe are now thought to be present in all known B. cereus group strains (24). 392 
In relation to cytK genes, cytK1 could not be detected in any of the 49 strains but cytK2 393 
was present in approximately 50% of them. Finally, only one strain (2%) harboured the 394 
complete hblCDA operon. Hbl and CytK-related genes are present in less than 50% of 395 
randomly sampled strains (40,41,42). Hbl is a three-component toxin complex and all 396 
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three components are necessary for maximal biological activity (43,44). In conclusion, 397 
B. cereus strains isolated from pasteurized milk in this study do not seem to possess a 398 
high virulence potential. 399 
Holder pasteurization did not significantly modify the concentration of any of 400 
the biochemical parameters analyzed in this work. Furosine and lactulose values are 401 
used to determine the effects of thermal treatment applied to milk or the addition of 402 
reconstituted milk powder to raw, pasteurized or UHT milk. In this work, furosine could 403 
not be detected in any of the samples, in contrast with the levels found in Holder and 404 
high-temperature (72ºC, 15 s) pasteurized milks, 6.9 - 10.0 and 6.7 - 20.3 mg/100g 405 
protein, respectively (45). This could be due to the low protein concentration present in 406 
human milk compared to cow’ milk. Furosine determination has gained broad attention 407 
by food chemists and biomedical researchers, as its formation upon heat treatment is 408 
well characterised. Moreover, it represents the Amadori products from early Maillard 409 
reactions in which amino acids react with reducing carbohydrates, resulting in a loss of 410 
their bioavailability. This is of importance for the essential amino acid lysine, which is 411 
also the limiting amino acid in many proteins.  412 
In the pasteurized samples where lactulose was detected, its content was higher 413 
than that found in Spanish pasteurized milks (45), a fact that may be attributed to the 414 
high content of lactose present in human milk. The lactulose concentrations were well 415 
below the limits considered acceptable for infant formulas. A correlation between 416 
lactulose and furosine exists (46,47), since both parameters are influenced by the 417 
intensity of the heating process and also by the storage conditions (48). However, the 418 
concentrations found here do not seem enough to negatively affect protein quality. 419 
No differences were found in the concentrations of lactose and glucose when the 420 
fresh samples of donor milk were divided in three groups on the basis of the duration of 421 
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lactation (transition milk, mature milk, late lactation milk). Interestingly, there was a 422 
statistically significant decrease of the concentration of myo-inositol in the samples as 423 
the lactation period increased. This finding is relevant since administration of myo-424 
inositol to premature infants with respiratory distress syndrome who are receiving 425 
parenteral nutrition is associated with increased survival without bronchopulmonary 426 
dysplasia or neural developmental handicap and with a decreased incidence of 427 
retinopathy (49). Serum myo-inositol concentration increases after birth in premature 428 
breastfed infants, while it tends to fall in those receiving parenteral nutrition (49). This 429 
reflects the fact that concentrations of myo-inositol are significantly higher in human 430 
milk than in infant formulas or parenteral nutrition solutions (50). Although the 431 
observation of a higher myo-inositol concentration in early milk is interesting, the 432 
comparison of the three lactation periods has limited value due to the reduced number of 433 
samples within each group. Therefore, more work is required in order to establish firm 434 
conclusions regarding its influence on preterm health.  435 
Globally, the results of this study showed that Holder pasteurization led to the 436 
destruction of bacteria present initially in donor milk samples, with the exception of 437 
some B. cereus strains that did not display a high virulence potential; in addition, the 438 
thermal treatment did not modify significantly the concentration of furosine and 439 
lactulose, two compounds that are used as markers for evaluating the extent of heat 440 
damage in cow’s milk and infant formulas. 441 
 442 
 443 
 444 
445 
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Legend to figures 572 
 573 
FIGURE 1. Lactose, glucose, and myo-inositol concentration in transition (TM, <15 574 
days, n = 4), mature (MM, 15-180 days, n = 8) and late lactation (LLM, >180 days, n = 575 
9) raw donor milk. The results of a one-way ANOVA and Bonferroni’s post hoc tests 576 
are shown by asterisks. 577 
* = P < 0.05; *** = P < 0.001. 578 
 579 
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TABLE 1. Bacterial counts in donor milk samples before and after Holder pasteurization 1 
      Range 
Medium 
Heat 
treatment 
Number of samples 
positive/total Mean SD 95% CI 
Minimum 
value 
Maximum 
value 
BHI NP 21/21 3.93 0.85 3.54 - 4.31 2.60 5.22 
 P 1/21 1.70*     
CNA NP 21/21 3.65 0.82 3.27 - 4.02 1.70 5.11 
 P 0/21 nd     
MCK NP 13/21 3.34 1.17 2.63 - 4.05 1.70 4.92 
 P 0/21 nd     
MRS NP 21/21 3.05 0.90 2.65 - 3.46 1.70 4.97 
 P 0/21 nd     
BP NP 21/21 3.28 0.92 2.86 -3.70 1.70 5.18 
 P 0/21 nd     
WCh NP 21/21 3.67 0.76 3.32 - 4.01 2.48 5.21 
 P 0/21 nd     
PEMBA NP 21/21 3.29 0.64 3.00 - 3.58 1.70 4.46 
 P 3/21 2.48†   2.00 3.44 
Values of mean, SD, 95% CI and range are expressed as log10 CFU/mL; BHI = Brain Heart Infusion; BP = Baird 2 
Parker; CI = confidence interval of the mean; CNA = Columbia Nadilixic Acid Agar; MCK = MacConkey; MRS = de 3 
Man, Rogosa, and Sharpe; nd = not detected; NP = non pasteurized samples; P = pasteurized samples; PEMBA = 4 
Polymyxin-Pyruvate-Egg Yolk-Mannitol with Bromothymol Blue; SD = standard deviation of the mean; WCh, 5 
Wilkins Chalgren. 6 
* Mean value of the samples where growth was detected. 7 
 8 
 9 
Tables
 2 
TABLE 2. Toxin gene profiles and toxin production by the B. cereus strains isolated from pasteurized samples 10 
  Toxin-encoding genes Toxin production 
RAPD Pattern Number of strains hblC hblD hblA nheA nheB nheC cytK1 cytK2 Hbl Nhe 
I 11 - - - + + + - - - + 
II 6 - - - + + + - + - + 
III 13 - + - + + + - - - + 
IV 17 - + - + + + - + - + 
V 1 + + + + + + - + + + 
VI 1 - - - + + - - - - + 
RAPD = random amplification polymorphic DNA. 11 
12 
 3 
TABLE 3. Effect of Holder pasteurization on the concentration of carbohydrates in donor milk samples 13 
analyzed 14 
     Range  
 n Mean SD 95% CI Minimum Maximum P
*
 
Lactose (g/L)        
NP 21 64.08 6.14 61.28 - 66.88 50.10 71.40  
P 21 65.50 7.20 62.22 - 68.78 51.14 75.96  
Change 21 1.42 2.89 0.10 - 2.74 -3.95 6.96 0.036 
Glucose (mg/L)        
NP 21 206.45 78.79 170.59 - 242.32 25.50 327.90  
P 21 199.63 76.78 164.68 - 234.58 24.90 305.11  
Change 21 -6.82 14.75 -13.53 - 0.11 -34.44  19.90 0.047 
Myo-inositol (mg/L)        
NP 21 196.45 104.40 148.93 - 243.97 58.30 459.00  
P 21 194.84 104.48 147.29 - 242.40 54.36 431.34  
Change 21 -1.61 19.95 -10.69 - 7.47 -30.53 53.33 0.716 
Lactulose (mg/L)        
NP 21 nd†      
P 8 
13 
nd 
18.96 
 
6.14 
 
15.25 - 22.67 
 
9.98 
 
33.98 
 
CI = confidence interval of the mean; NP = non pasteurized samples; P = pasteurized samples; SD = 15 
standard deviation of the mean. 16 
*
 Paired Student’s t-test. 17 
† Below the detection limit of the method (10 mg/L). 18 
